ACTs remain effective in The Gambia, supported by the absence of pfkelch13 mutations. However, reversion to chloroquine sensitivity tend to result in reduced sensitivity to ACT drugs. These genotype-phenotype dynamics needs continuous monitoring to guide drug interventions towards malaria elimination.
Drammeh et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: